European Code against Cancer

from Wikipedia, the free encyclopedia

The European Code Against Cancer (the original English: European Code against Cancer ) is a code of conduct , or a set of recommendations for the citizens of the European Union , based on scientific evidence. The aim of this code is to reduce the number of people who develop cancer each year in the EU.

The code

In 1987 a committee of several cancer researchers developed and published a code to combat cancer. The European Commission has the early 1990s, the European School of Oncology , headquartered in Milan prompted to make a review and revision of the Code and its recommendations. In 1995 the second edition of the code was adopted and published. The third and currently current version of the code was created in 2003. It was funded by the European Commission's Europe against Cancer program . The European Parliament supports the dissemination of this code.

The Code itself gives various recommendations for the daily life of EU citizens, such as smoking cessation, healthy eating and leisure activities, as well as cancer screening.

Evaluation of the code

In 1985 there were 850,194 cancer deaths in the EU. On the basis of pure demographic developments, an increase to 1,033,083 by the year 2000 was assumed. In fact, there was also an increase in cancer deaths during this period, by 12% in men and 9% in women. The goal set by the European Code of Practice to Fight Cancer of 15% fewer cancer deaths than in 1985 was not achieved throughout the EU during this period. In fact, a 10% reduction in the death rate for men and 8% for women and a risk reduction of 11 and 10%, respectively, could be demonstrated. Austria and Finland alone achieved the target of a 15% reduction in the death rate from cancer compared to 1985. The United Kingdom and Luxembourg came close to achieving the target. Portugal and Greece performed worst. The authors conclude that the introduction of the code and its dissemination may be linked to the prevention of 92,573 new cancer deaths. In most of the EU countries there have since been declines in cancer deaths. In the last three to four years in particular, the breast cancer and cervical cancer screening and preventive examinations that have been introduced are expected to play a role in further reducing cancer mortality.

The members of the committee

The committee for updating the code consisted of more than 40 experts from various areas of cancer research. These were:

  • Peter Boyle , President, International Prevention Research Institute , Lyon, France as project leader
  • Philippe Autier, Group Leader, International Agency for Research on Cancer , Lyon, France
  • Jose Baselga, Professor and Chairman, Medical Oncology Service, Vall d'Hebron University Hospital, Barcelona, ​​Spain
  • Paolo Boffetta, Head, Section of Environment, International Agency for Research on Cancer , Lyon, France
  • John Burn Medical Director and Director, Institute of Human Genetics, Newcastle University , Newcastle, United Kingdom
  • Harry JG Burns, Chief Medical Officer, NHS Scotland, Glasgow, United Kingdom
  • Mario Dicato Professor and Head of Internal Medicine, Dept. of Hematology-Oncology, Center Hospitalier de Luxembourg, Luxembourg
  • Volker Diehl, emeritus professor and former director, Clinic I for Internal Medicine, University of Cologne , Cologne, Germany
  • Richard Doll , Former Professor, University of Oxford , Oxford, United Kingdom
  • Miklos Kásler, Director, National Institute of Oncology, Budapest, Hungary
  • Manolis Kogevinas, Professor, Department of Epidemiology and Public Health, Institut Municipal d'Investigacio Mèdica (IMIM), Barcelona, ​​Spain and Co-Director, Center for Research in Environmental Epidemiology (CREAL), Barcelona, ​​Spain
  • Stener Kvinnsland, Director, Haukeland University Hospital, Bergen, Norway
  • Carlo La Vecchia, Professor and Head, Department of Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
  • Gordon McVie, Professor and Senior Consultant, Department of Epidemiology and Biostatistics, European Institute of Oncology , Milan, Italy
  • José Maria Martin-Moreno, Professor and Director, Department for Preventive Medicine and Public Health, University of Valencia, Valencia, Spain
  • Mike Richards (Medical Doctor), National Cancer Director, St Thomas' Hospital , London, United Kingdom
  • Ulrik Ringborg, Department of Oncology, Radiumhemmet, Karolinska Institute and Karolinska Hospital , Solna, Sweden
  • Crispian Scully, Dean and Director of Education and Research, Eastman Dental Institute for Oral Health Care Sciences and International Centers for Excellence in Dentistry, University College London , London, UK
  • Umberto Veronesi, Professor, Founder and Scientific Director, European Institute of Oncology , Milan, Italy
  • Harald zur Hausen Former Director, German Cancer Research Center , Heidelberg, Germany

bibliography

Web links

Individual evidence

  1. ↑ Europe against cancer viewed on June 17, 2009
  2. ↑ MEPs Against Cancer - Statement ( Memento of the original from July 26, 2010 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. Accessed June 17, 2009  @1@ 2Template: Webachiv / IABot / www.mepsagainstcancer.org
  3. ↑ Scientific publication (in English) to prove the success of the code, 2003